高级搜索
A蛋白类制剂体内抗肿瘤效应与联合化疗的研究[J]. 肿瘤防治研究, 1991, 18(3): 151-153.
引用本文: A蛋白类制剂体内抗肿瘤效应与联合化疗的研究[J]. 肿瘤防治研究, 1991, 18(3): 151-153.
INVESTIGATION ON ANTITUMOR EFFECT STRENGTH OF PROTEIN A AGENTS AND COMBINATION WITH CHEMOTHERAPY IN VIVO[J]. Cancer Research on Prevention and Treatment, 1991, 18(3): 151-153.
Citation: INVESTIGATION ON ANTITUMOR EFFECT STRENGTH OF PROTEIN A AGENTS AND COMBINATION WITH CHEMOTHERAPY IN VIVO[J]. Cancer Research on Prevention and Treatment, 1991, 18(3): 151-153.

A蛋白类制剂体内抗肿瘤效应与联合化疗的研究

INVESTIGATION ON ANTITUMOR EFFECT STRENGTH OF PROTEIN A AGENTS AND COMBINATION WITH CHEMOTHERAPY IN VIVO

  • 摘要: 本文旨在比较A蛋白类制剂(SPA、SAC和SAW)与CP的体内抗肿瘤效应,确定它们的免疫保护强度,寻找提高其免疫疗效的方法。结果表明,A蛋白类制剂体内抗实验性肿瘤的疗效接近CP,尽管它们不足以对付107瘤细胞(EAC)的攻击,但其疗效可通过与化疗药物的联合应用而提高。

     

    Abstract: The paper'S aim was to compare the antitumor effects of protein A agents (i. e. SPA. SAC and SAW) with those of CP. to confirm the immunoprotective strength, and to look for the approach of raising their immunotherapeutic effects. The results showed that the therapeutic effect of protein A agents injected directly into tumor-bearing animals was similar to those of CP. although they could not be enough to cope with challenge for as high as 10~7 tumor (EAC) cells but thetr therapeutic effects could be significantly enchanced by combination with chemotherapeutic drugs.

     

/

返回文章
返回